What we can know from the research is that has-miR-6086 can directly or indirectly downregulate the OC2 (onecut2)/VEGFA/EGFL6 (EGF-like domain multiple 6) axes to inhibit the angiogenesis network in OC, and may become a new research hotspot as an underlying target for tumor therapy [39]. Here, EGFL6 is linked to neoplasm.